• 文献检索
  • 文档翻译
  • 深度研究
  • 学术资讯
  • Suppr Zotero 插件Zotero 插件
  • 邀请有礼
  • 套餐&价格
  • 历史记录
应用&插件
Suppr Zotero 插件Zotero 插件浏览器插件Mac 客户端Windows 客户端微信小程序
定价
高级版会员购买积分包购买API积分包
服务
文献检索文档翻译深度研究API 文档MCP 服务
关于我们
关于 Suppr公司介绍联系我们用户协议隐私条款
关注我们

Suppr 超能文献

核心技术专利：CN118964589B侵权必究
粤ICP备2023148730 号-1Suppr @ 2026

文献检索

告别复杂PubMed语法，用中文像聊天一样搜索，搜遍4000万医学文献。AI智能推荐，让科研检索更轻松。

立即免费搜索

文件翻译

保留排版，准确专业，支持PDF/Word/PPT等文件格式，支持 12+语言互译。

免费翻译文档

深度研究

AI帮你快速写综述，25分钟生成高质量综述，智能提取关键信息，辅助科研写作。

立即免费体验

The impact of a multidisciplinary cardio-oncology programme on cardiovascular outcomes in Taiwan.

作者信息

Chang Wei-Ting, Feng Yin-Hsun, Kuo Yu Hsuan, Chen Wei-Yu, Wu Hong-Chang, Huang Chien-Tai, Wang Wen-Ching, Liao Chia-Te, Chen Zhih-Cherng

机构信息

Division of Cardiology, Department of Internal Medicine, Chi-Mei Medical Center, 901, Zhonghua Road, Tainan, Taiwan.

Department of Biotechnology, Southern Taiwan University of Science and Technology, Tainan, Taiwan.

出版信息

ESC Heart Fail. 2020 Oct;7(5):2135-2139. doi: 10.1002/ehf2.12840. Epub 2020 Jul 4.

DOI:10.1002/ehf2.12840
PMID:32621792
原文链接:https://pmc.ncbi.nlm.nih.gov/articles/PMC7524067/
Abstract
摘要
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/ae2e/7524067/f9e9101987a2/EHF2-7-2135-g002.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/ae2e/7524067/9713bc35a250/EHF2-7-2135-g001.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/ae2e/7524067/f9e9101987a2/EHF2-7-2135-g002.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/ae2e/7524067/9713bc35a250/EHF2-7-2135-g001.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/ae2e/7524067/f9e9101987a2/EHF2-7-2135-g002.jpg

相似文献

1
The impact of a multidisciplinary cardio-oncology programme on cardiovascular outcomes in Taiwan.多学科心脏肿瘤项目对台湾心血管结局的影响。
ESC Heart Fail. 2020 Oct;7(5):2135-2139. doi: 10.1002/ehf2.12840. Epub 2020 Jul 4.
2
The Cardio-oncology Program: A Multidisciplinary Approach to the Care of Cancer Patients With Cardiovascular Disease.肿瘤心脏病学计划：心血管疾病癌症患者护理的多学科方法。
Can J Cardiol. 2016 Jul;32(7):847-51. doi: 10.1016/j.cjca.2016.04.014. Epub 2016 May 6.
3
Brazilian cardio-oncology: the 10-year experience of the Instituto do Cancer do Estado de Sao Paulo.巴西心血管肿瘤学：圣保罗州立癌症研究所的 10 年经验。
BMC Cardiovasc Disord. 2020 Apr 28;20(1):206. doi: 10.1186/s12872-020-01471-8.
4
Cardio-oncology: an ongoing evolution.心脏肿瘤学：不断发展
Future Oncol. 2015;11(14):2059-66. doi: 10.2217/fon.15.89.
5
Rationale for Cardio-Oncology Units.心脏肿瘤学科室的基本原理。
Rev Esp Cardiol (Engl Ed). 2017 Jul;70(7):583-589. doi: 10.1016/j.rec.2017.02.006. Epub 2017 Mar 16.
6
Current Status of Cardio-Oncology in Spain: A National Multidisciplinary Survey.
Rev Esp Cardiol (Engl Ed). 2019 Jan;72(1):84-86. doi: 10.1016/j.rec.2017.11.002. Epub 2017 Dec 6.
7
[Cardio-oncology, why is it a new specialty ?].[心脏肿瘤学，为何它是一门新兴专科？]
Rev Med Liege. 2021 May;76(5-6):408-412.
8
Cardio-Oncology rehabilitation- challenges and opportunities to improve cardiovascular outcomes in cancer patients and survivors.肿瘤心脏病学康复——改善癌症患者和幸存者心血管结局的挑战和机遇。
J Cardiol. 2020 Dec;76(6):559-567. doi: 10.1016/j.jjcc.2020.07.014. Epub 2020 Jul 28.
9
A Cardio-Oncology Data Commons: Lessons from Pediatric Oncology.心血管肿瘤学数据共享：儿科肿瘤学的经验教训。
Curr Cardiol Rep. 2019 Sep 13;21(10):128. doi: 10.1007/s11886-019-1212-y.
10
Status of cardio-oncology in Australia in 2021: a nationwide multidisciplinary survey.2021年澳大利亚心脏肿瘤学现状：一项全国性多学科调查
Intern Med J. 2022 Feb;52(2):341-342. doi: 10.1111/imj.15682.

引用本文的文献

1
Advance at a glance: contributions to cardio-oncology.一目了然：对心脏肿瘤学的贡献。
Eur Heart J Open. 2025 Jun 20;5(3):oeaf075. doi: 10.1093/ehjopen/oeaf075. eCollection 2025 May.
2
Quality-of-Care Measures for Cardio-Oncology: An IC-OS and ACC Cardio-Oncology Leadership Council Perspective.心脏肿瘤学的医疗质量指标：国际心脏肿瘤学会（IC-OS）和美国心脏病学会（ACC）心脏肿瘤学领导委员会观点
JACC CardioOncol. 2025 Apr;7(3):191-202. doi: 10.1016/j.jaccao.2024.11.003. Epub 2025 Jan 7.
3
Advancing Cardio-Oncology in Asia.推动亚洲心血管肿瘤学发展。

本文引用的文献

1
Cardio-Oncology: Vascular and Metabolic Perspectives: A Scientific Statement From the American Heart Association.心血管肿瘤学：血管和代谢视角：美国心脏协会的科学声明。
Circulation. 2019 Mar 26;139(13):e579-e602. doi: 10.1161/CIR.0000000000000641.
2
Activity and outcomes of a cardio-oncology service in the United Kingdom-a five-year experience.英国心脏肿瘤学服务的活动和成果：五年经验。
Eur J Heart Fail. 2018 Dec;20(12):1721-1731. doi: 10.1002/ejhf.1292. Epub 2018 Sep 6.
3
Cardiotoxicity and Cardiac Monitoring Among Chemotherapy-Treated Breast Cancer Patients.
Korean Circ J. 2023 Feb;53(2):69-91. doi: 10.4070/kcj.2022.0255.
4
An artificial intelligence approach for predicting cardiotoxicity in breast cancer patients receiving anthracycline.人工智能方法预测接受蒽环类药物治疗的乳腺癌患者的心脏毒性。
Arch Toxicol. 2022 Oct;96(10):2731-2737. doi: 10.1007/s00204-022-03341-y. Epub 2022 Jul 25.
化疗治疗乳腺癌患者的心脏毒性和心脏监测。
JACC Cardiovasc Imaging. 2018 Aug;11(8):1084-1093. doi: 10.1016/j.jcmg.2018.06.005.
4
Role of Biomarkers in Prediction of Cardiotoxicity During Cancer Treatment.生物标志物在癌症治疗期间心脏毒性预测中的作用。
Curr Treat Options Cardiovasc Med. 2018 Jun 19;20(7):55. doi: 10.1007/s11936-018-0641-z.
5
Diagnosis, Treatment, and Prevention of Cardiovascular Toxicity Related to Anti-Cancer Treatment in Clinical Practice: An Opinion Paper from the Working Group on Cardio-Oncology of the Korean Society of Echocardiography.临床实践中抗癌治疗相关心血管毒性的诊断、治疗及预防：韩国超声心动图学会心脏肿瘤学工作组的意见书
J Cardiovasc Ultrasound. 2018 Mar;26(1):1-25. doi: 10.4250/jcu.2018.26.1.1. Epub 2018 Mar 28.
6
Carvedilol for Prevention of Chemotherapy-Related Cardiotoxicity: The CECCY Trial.卡维地洛预防化疗相关性心脏毒性：CECCY 试验。
J Am Coll Cardiol. 2018 May 22;71(20):2281-2290. doi: 10.1016/j.jacc.2018.02.049. Epub 2018 Mar 11.
7
Cardiac complications of chemotherapy: role of imaging.化疗的心脏并发症：影像学的作用。
Curr Treat Options Cardiovasc Med. 2014 Apr;16(4):296. doi: 10.1007/s11936-014-0296-3.
8
Emerging paradigms in cardiomyopathies associated with cancer therapies.与癌症治疗相关的心肌病的新兴范式。
Circ Res. 2013 Aug 30;113(6):754-64. doi: 10.1161/CIRCRESAHA.113.300218.
9
Left ventricular dysfunction in patients receiving cardiotoxic cancer therapies are clinicians responding optimally?接受心脏毒性癌症治疗的患者的左心室功能障碍，临床医生是否做出了最佳反应？
J Am Coll Cardiol. 2010 Nov 9;56(20):1644-50. doi: 10.1016/j.jacc.2010.07.023.